Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does BLESELUMAB Cause Transplant rejection? 6 Reports in FDA Database

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

According to the FDA Adverse Event Reporting System (FAERS), 6 reports of Transplant rejection have been filed in association with BLESELUMAB. This represents 10.9% of all adverse event reports for BLESELUMAB.

6
Reports of Transplant rejection with BLESELUMAB
10.9%
of all BLESELUMAB reports
0
Deaths
3
Hospitalizations

How Dangerous Is Transplant rejection From BLESELUMAB?

Of the 6 reports, 3 (50.0%) required hospitalization.

Is Transplant rejection Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for BLESELUMAB. However, 6 reports have been filed with the FAERS database.

What Other Side Effects Does BLESELUMAB Cause?

Acute kidney injury (9) Kidney transplant rejection (9) Focal segmental glomerulosclerosis (6)

What Other Drugs Cause Transplant rejection?

TACROLIMUS (3,526) MYCOPHENOLATE MOFETIL (2,500) PREDNISONE (1,111) CYCLOSPORINE (903) PREDNISOLONE (860) METHYLPREDNISOLONE (779) SIROLIMUS (698) BASILIXIMAB (554) MYCOPHENOLIC ACID (445) LAPINE T-LYMPHOCYTE IMMUNE GLOBULIN (437)

Related Pages

BLESELUMAB Full Profile All Transplant rejection Reports All Drugs Causing Transplant rejection BLESELUMAB Demographics